Vista Gold Corp. Announces Favorable Changes to the Northern Territory, Australia Mineral Royalties Regime
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista†or the “Companyâ€) today announced…
2 years ago
IN7.com LDT Spreads Love: 300+ Gifts Delivered to African Children’s Charities Homes
DELHI, INDIA - Media OutReach Newswire - 11 June 2024 - As a well-established game…
2 years ago
Netcracker Launches Pioneering Solution to Accelerate Digitization in Satellite Communications
Netcracker Digital Satellite Solution Revolutionizes LEO and GEO Satellite Communication Ground Networks With Real-Time Operations,…
2 years ago
Anteris Provides Data Update on First in Human Study of DurAVRâ„¢ THV Presented at New York Valves 2024
BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVRâ„¢…
2 years ago
Trellix Uncovers Spike in Cyber Activity from China and Russia
Report details shifting ransomware ecosystem, U.S. election themed scams, and emergence of new AI tools…
2 years ago
Tolaram adds Guinness Nigeria to roster of brands in flourishing consumer goods business
Singapore conglomerate to acquire Diageo’s shareholding in the West African brewery business and continue building…
2 years ago
London Square’s spectacular showcase at Rosewood Hong Kong provides a dazzling view of its UK new homes
HONG KONG SAR - Media OutReach Newswire - 11 June 2024 - Leading UK residential…
2 years ago
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation
V-Nova’s IP portfolio surpassed 1000 active patents across 50+ countries in just 12 years Approximately…
2 years ago
Vonage and Telstra Partner to help Accelerate Digital Transformation with Network APIs
By combining Telstra’s network APIs with Vonage’s API platform and Ericsson’s 5G network capabilities, enterprises…
2 years ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…
2 years ago